Zhengye Biotechnology Holding Limited Research and Development Expense
Zhengye Biotechnology Holding Limited (ZYBT) reported Research and Development Expense of CNY 18.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-28
CNY
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | 18.01M CNY 20-F · filed 2026-04-28 | |
| 2025-06-30 | 8.97M CNY 6-K · filed 2025-12-12 | |
| 2024-12-31 | 12.79M CNY 20-F · filed 2026-04-28 | |
| 2024-06-30 | 5.44M CNY 6-K · filed 2025-12-12 | |
| 2023-12-31 | 11.90M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 13.42M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $2.58M 20-F · filed 2026-04-28 | |
| 2025-06-30 | $1.25M 6-K · filed 2025-12-12 | |
| 2024-12-31 | $1.75M 20-F · filed 2025-07-03 |